Consulting people who use cannabis to plan a regulatory trial on non-medical cannabis sales in pharmacies
This experience showed that gathering user input is feasible, even in highly regulated, stigmatized contexts. Including the perspectives of people who use cannabis in the trial set-up allowed the research team to adapt the study intervention. Where they could not adapt the study intervention, it helped them prepare for possible reactions from future study participants and disseminate their findings to other stakeholders. Future research should test the feasibility and benefits of such activities throughout all research stages.
Authors
- Marie‐Anne Durand (ORCID: https://orcid.org/0000-0002-1127-9348)
- Kevin J. Selby (ORCID: https://orcid.org/0000-0002-9096-0720)
- Natalia S. Andryashina (ORCID: https://orcid.org/0000-0002-0236-4102)
- Reto Auer (ORCID: https://orcid.org/0000-0003-4222-4849)
- n n
- Fat h.
- Beatrice Metry
- Anna Irina Schibli
- Kathrin Bieri
Institutions
- Dartmouth College (US)
- University of Bern (CH)
- Dartmouth Institute for Health Policy and Clinical Practice (US)
- Bern University of Applied Sciences (CH)
- Advisory Board Company (United States) (US)
- Universidad Iberoamericana (DO)
- Centre universitaire de médecine générale et santé publique, Lausanne (CH)
- University of Lausanne (CH)
Publication Details
- Journal
- Research Involvement and Engagement
- Published
- 2025-10-24
- DOI
- https://doi.org/10.1186/s40900-025-00791-3
- Primary Topic
- Cannabis and Cannabinoid Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Science Foundation
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung